Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 12, Issue 6, 1998, Pages 633-638

  Williams, Glyn D ^a,b   Bratton, Susan L ^a   Nielsen, Nancy J ^a   Ramamoorthy, Chandra ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cardiopulmonary bypass; Child; Fibrinolysis; Heart surgery; Thromboelastography

Indexed keywords

AMINOCAPROIC ACID; D DIMER; FIBRINOGEN; HEPARIN; PROTAMINE; THROMBIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBRINOLYSIS; HEART OUTPUT; HEMATOCRIT; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

EID: 0032439432     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(98)90233-6     Document Type: Article

References (41)

1. Manno CS, Hedberg KW, Kim HC, et al: Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open-heart surgery in children. Blood 77:930-936, 1991
2. Kern FH, Morana NJ, Sears JJ, Hickey PR: Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 54:541-546, 1992
3. Petaja J, Lundstrom U, Leijala M, et al: Bleeding and the use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 109:524-529, 1995
4. Guay J, Rivard GE: Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 62:1955-1960, 1996
5. Woodman RC, Harker LA: Bleeding complications associated with cardiopulmonary bypass. Blood 76:1680-1697, 1990
6. Chan AK, Leaker M, Burrows FA, et al: Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77:270-277, 1997
7. Tanaka K, Takao M, Yada I, et al: Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Vase Anesth 3:181-188, 1989
8. Spiess BD: The contribution of fibrinolysis to postbypass bleeding. J Cardiothorac Vase Anesth 5:13-17, 1991 (suppl 1)
9. Dietrich W, Mossinger H, Spannagl M, et al: Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Cardiovasc Surg 105:712-720, 1993
10. Saatvedt K, Lindberg H, Michelsen S, et al: Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open-heart surgery in children. Scand J Clin Lab Invest 55:359-367, 1995
11. Chandler WL, Fitch JC, Wall MH, et al: Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost 74:1293-1297, 1995
12. Kang Y: Clinical use of synthetic antifibrinolytic agents during liver transplantation. Semin Thromb Hemost 19:258-261, 1993
13. Spiess BD, Logas WG, Tuman KJ, et al: Thromboelastography used for detection of perioperative fibrinolysis: A report of four cases. J Cardiothorac Vase Anesth 2:666-672, 1988
14. Spiess BD, Wall MH, Gillies BS, et al: A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Thromb Haemost 78:820-826, 1997
15. Spiess BD, Tuman KJ, McCarthy RJ, et al: Thromboelastography as an indicator of post - cardiopulmonary bypass coagulopathies. J Clin Monit 3:25-30, 1987
16. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD: Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 69:69-75, 1989
17. Mallett SV, Cox DJ: Thromboelastography. B J Anaesth 69:307-313, 1992
18. Miller BE, Mochizuki T, Levy JH, et al: Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 85:1196-1202, 1997
19. Wall MH, Spiess BD, Gillies B, Chandler WL: Thromboelastography with added heparinase or protamine sulfate during cardiopulmonary bypass. Anesthesiology 79:A96, 1993
20. Boldt J, Knothe C, Zickmann B, et al: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac opera-lions. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 105:705-711, 1993
21. Chambers LA, Cohen DM, Davis JT: Transfusion patterns in pediatric open-heart surgery. Transfusion 36:150-154, 1996
22. Andrew M, Paes B, Milner R, et al: Development of the human coagulation system in the full-term infant. Blood 70:165-172, 1987
23. Andrew M, Vegh P, Johnston M, et al: Maturation of the hemostatic system during childhood. Blood 80:1998-2005, 1992
24. Andrew M, Paes B, Milner R, et al: Development of the human coagulation system in the healthy premature infant. Blood 72:1651-1657, 1988
25. Andrew M, Marzinotto V, Massicotte P, et al: Heparin therapy in pediatric patients: A prospective cohort study. Pediatr Res 35:78-83, 1994
26. D'Errico CM, Shayevitz J, Martindale SJ: Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients. J Cardiothorac Vase Anesth 10:451-457, 1996
27. Mace S, Borkat G, Liebman J: Hepatic dysfunction and cardio-vascular abnormalities. Am J Dis Child 139:60-65, 1985
28. Gill JC, Wilson AD, Endres-Brooks J, et al: Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital heart defects. Blood 67:758-761, 1986
29. Wyss M, Babel JF, Rouge JC, Bouvier CA: Haemostatic changes during open-heart surgery with extracorporeal circulation and deep hypothermia in children. Anaesthesist 31:82-86, 1982
30. Journois D, Mauriat P, Pouard P, et al: Assessment of coagulation factor activation during cardiopulmonary bypass with a new monoclonal antibody. J Cardiothorac Vase Anesth 8:157-161, 1994
31. 1+2. Thromb Haemost 70:253-258, 1993
32. Turner-Gomes SO, Mitchell L, Williams WG, Andrew M: Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 107:562-568, 1994
33. Gelb AB, Roth RI, Levin J, et al: Changes in blood coagulation during and following cardiopulmonary bypass: Lack of correlation with clinical bleeding. Am J Clin Path 106:87-99, 1996
34. Grant HW, Hadley GP: Prediction of neonatal sepsis by thromboelastography. Pediatr Surg Int 12:289-292, 1997
35. Steinbrueckner BE, Steigerwald U, Keller F, et al: Centrifugal and roller pumps - Are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass? Heart Vessels 10:46-53, 1995
36. Edmunds LH Jr: Aprotinin use in pediatric cardiac operations. J Thorac Cardiovasc Surg 105:757-760, 1993
37. Reid RW, Zimmerman AA, Laussen PC, et al: The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 84:990-996, 1997
38. D'Errico CC, Shayevitz JR, Martindale SJ, et al: The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 83:1193-1199, 1996
39. Spiess BD: Thromboelastography and cardiopulmonary bypass. Semin Thromb Hemost 21:27-33, 1995
40. Hunt BJ, Segal H: Hyperfibrinolysis. J Clin Path 49:958, 1996
41. Comunale ME, Carr JM, Moorman RM, Robertson LK: Significance of D-dimer concentrations during and after cardiopulmonary bypass. J Cardiothorac Vase Anesth 10:477-481, 1996